Institut Curie is recruiting 11 PhD students through its international program called EuReCa (Europe, Resarch & Care).
This program, part funded by the European Commission’s MSCA COFUND scheme, provides PhD students with a 3-year doctoral contract, a high level interdisciplinary, inter-sectorial, as well as international training and coaching sessions with personalized career development plans, secondments and mentoring.
PhD research projects in life sciences cover Institut Curie’s main research domains:
✓ Biology & Chemistry of Radiations, Cell Signaling & Cancer
✓ Development, Cancer, Genetics & Epigenetics
✓ Integrative Tumour Biology, Immunology & Environment
✓ Multiscale Physics-Biology-Chemistry & Cancer
✓ Translational Research
Institut Curie brings together a world-class multidisciplinary cancer research center and a model hospital group in Paris and surroundings. By embracing cross-disciplinary approaches, it drives the discovery of more effective treatments and leads to improved patient care.
Covid-19 notice: Please note that the entire recruitment process will be done online and all necessary precautions will be taken on arrival according to the sanitary situation in September 2021.
Acentrosomal microtubule organization in neural stem cells
Thesis supervisor(s): Alexandre Baffet
Research group: Cell Biology of Mammalian Neurogenesis
Deciphering the role of transcription-replication conflict and R-loop in causing genome instability in breast cancer
Thesis supervisor(s): Chunlong Chen
Research group: Replication Program and Genome Instability
Extracellular Vesicles in invasion, metastasis and ferroptosis resistance: a specific role for CD133/Prominin in aggressive gastrointestinal carcinoma
Thesis supervisor(s): Gisela D’Angelo & Sarah Watson
Research group: Structure and Membrane Compartments
A multidisciplinary approach to determine the 3-dimensional organization of centromeres in mitosis
Thesis supervisor(s): Ines Drinnenberg
Research group: Evolution of Centromeres and Chromosome Segregation
Characterization of the functions of protein arginine methyltransferase 4 (PRMT4/CARM1) in triple-negative breast cancers
Thesis supervisor(s): Thierry Dubois
Research group: Breast Cancer Biology
Novel chemical tools to study base-excision DNA repair
Thesis supervisor(s): Anton Granzhan & Sophie Bombard
Research group: Chemistry for Nucleic Acid Recognition
Control of gut development and physiology by cytokine signaling
Thesis supervisor(s): Pedro Hernandez
Research group: Development and Homeostasis of Mucosal Tissues
Immune and epigenetic biomarkers assessments based on a basket prospective trial with Pembrolizumab and Vorinostat in patients with late stage squamous cell carcinoma
Thesis supervisor(s): Christophe Le Tourneau & Nicolas Servant
Research group: Bioinformatics and Computational Systems Biology of Cancer
Mechanotransduction at the Golgi apparatus
Thesis supervisor(s): Jean-Baptiste Manneville & Stéphanie Miserey-Lenkei
Research group: Molecular Mechanisms of Intracellular Transport
Genetic determinants of tumor microenvironment in high grade serous ovarian carcinomas
Thesis supervisor(s): Marc-Henri Stern & Manuel Rodrigues
Research group: DNA Repair and Uveal Melanoma
Comparative mechanisms of spindle assembly dynamics and scaling
Thesis supervisor(s): Phong Tran & François Nedelec
Research group: Cytoskeletal Architecture and Cell Morphogenesis
1. Early-stage researchers (ESR) shall at the call deadline be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.
Full-time equivalent research experience is measured from the date when a researcher obtained the degree which would formally entitle him or her to embark on a doctorate.
2. Applicants may not have resided or carried out their main activity (work, studies, etc.) in France for more than 12 months in the 3 years prior to January 14th, 2021.
Time spent as part of a procedure for obtaining refugee status under the Geneva Convention, compulsory national service and/ or short stays such as holidays are not taken into account.
3. Applicants must be in possession of a European master degree or equivalent master’s degree which would formally entitle them to embark on a doctorate.
Application deadline: January 28th, 2021 at 4:00pm (CET)
Candidates have to complete an online form in English in time via the web-based application portal. Applications will be evaluated through a three-step process:
- Eligibility check of applications in Jan.-Feb. 2021
- 1st round selection: Evaluation & ranking of applications by the Review Board in March-April 2021
- 2nd round selection: Shortlisted candidates are invited for an online interview session by the Selection Committee in May 19-21, 2021.
Final results will be given in June 2021. Start of PhD on September 1st, 2021.
The EuReCa PhD Program is in English.
International students willing to apply for the EuReCa PhD Program should inquire about the visa procedure regarding their country.
Web site for application & more details:
Please indicate that you saw this advert on Academic Keys when applying.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie actions grant agreement no. 847718.
About the employer
- The mission of Institut Curie’s Research Centre is to understand the complex workings of both normal and cancerous cells in their environment in an effort to find innovative and increasingly effective therapeutic approaches.